2. Metabolic Enzyme/Protease
  3. Phospholipase
  4. Giripladib

Giripladib (PLA-695) is a indole-based inhibitor of cytosolic phospholipase A2 (cPLA2). Giripladib can be used for osteoarthritis and breast cancer research.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

Giripladib

Giripladib Chemical Structure

CAS No. : 865200-20-0

Size Prix Stock Quantité
1 mg En stock
5 mg En stock
10 mg En stock
50 mg   Obtenir un devis  
100 mg   Obtenir un devis  

* Veuillez sélectionner la quantité avant d'ajouter des articles.

This product is a controlled substance and not for sale in your territory.

Avis client

Based on 1 Customer Validation

Giripladib Related Antibodies

Top Publications Citing Use of Products

Voir tous les produits spécifiques à Isoform Phospholipase:

Voir toutes les isoformes
Phospholipase A PLD Phospholipase C

  • Activité biologique

  • Pureté et documentation

  • Références

  • Avis client

Description

Giripladib (PLA-695) is a indole-based inhibitor of cytosolic phospholipase A2 (cPLA2). Giripladib can be used for osteoarthritis and breast cancer research[1][2].

IC50 & Target

cPLA2α

 

Essai clinique
Masse moléculaire

745.25

Formule

C41H36ClF3N2O4S
CAS No.
Appearance

Solid

Color

White to light yellow

SMILES

O=C(C1=CC=C(CCCC2=C(CCNS(=O)(CC3=C(C(F)(F)F)C=CC=C3)=O)N(C(C4=CC=CC=C4)C5=CC=CC=C5)C6=C2C=C(C=C6)Cl)C=C1)O
Livraison

Room temperature in continental US; may vary elsewhere.
Stockage
Powder -20°C 3 years
In solvent -80°C 6 months
-20°C 1 month
Solvant et solubilité
In Vitro: 

DMSO : 125 mg/mL (167.73 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 1.3418 mL 6.7092 mL 13.4183 mL
5 mM 0.2684 mL 1.3418 mL 2.6837 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Calculateur de molarité

  • Calculateur de dilution

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
Pureté et documentation
Références

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 1.3418 mL 6.7092 mL 13.4183 mL 33.5458 mL
5 mM 0.2684 mL 1.3418 mL 2.6837 mL 6.7092 mL
10 mM 0.1342 mL 0.6709 mL 1.3418 mL 3.3546 mL
15 mM 0.0895 mL 0.4473 mL 0.8946 mL 2.2364 mL
20 mM 0.0671 mL 0.3355 mL 0.6709 mL 1.6773 mL
25 mM 0.0537 mL 0.2684 mL 0.5367 mL 1.3418 mL
30 mM 0.0447 mL 0.2236 mL 0.4473 mL 1.1182 mL
40 mM 0.0335 mL 0.1677 mL 0.3355 mL 0.8386 mL
50 mM 0.0268 mL 0.1342 mL 0.2684 mL 0.6709 mL
60 mM 0.0224 mL 0.1118 mL 0.2236 mL 0.5591 mL
80 mM 0.0168 mL 0.0839 mL 0.1677 mL 0.4193 mL
100 mM 0.0134 mL 0.0671 mL 0.1342 mL 0.3355 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Giripladib Related Classifications

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Giripladib865200-20-0PLA-695PLA695PLA 695PhospholipaseOsteoarthritisBCSCstumorigenesisbreast cancer stem cellscytosolic phospholipase A2Inhibitorinhibitorinhibit

Vos produits récemment consultés:

Demande en ligne

Your information is safe with us. * Required Fields.

Nom du produit

  

Requested Quantity *

Nom du demandeur *

 

Civilité

Adresse e-mail *

 

Numéro de téléphone *

Department

 

Nom de l'organisation *

City

État

Country or Region *

      

Remarques

Bulk Inquiry

Inquiry Information

Nom du produit:
Giripladib
Cat. No.:
HY-14952
Quantité:
MCE Japan Authorized Agent:

Avis client

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Nom du produit

  

Lot #

Nom du demandeur *

 

Adresse e-mail *

Numéro de téléphone

 

Department *

Nom de l'organisation *

 

Country or Region *

Remarques

SAFETY DATA SHEET (SDS)

English - EN (251 KB) Français - FR (251 KB) Deutsch - DE (251 KB) Norwegian - NO (251 KB) Español - ES (251 KB) Swedish - SV (251 KB) Italian - IT (251 KB) Korean - KR (251 KB) Portuguese - PT (251 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.